Market: NYQ |
Currency: USD
Address: 9001 Spectrum Center Boulevard
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Show more
📈 ResMed Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$307.95
-
Upside/Downside from Analyst Target:
22.02%
-
Broker Call:
32
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
10-25%
-
Net Income Growth Range (1Y):
10-25%
-
Revenue Growth Range (1Y):
0-10%
-
Upcoming Earnings Date:
2026-05-01
-
EPS Estimate:
2.81
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for ResMed Inc.
| Date | Reported EPS |
|---|
| 2026-04-30 (estimated upcoming) | - |
| 2026-01-29 | 2.81 |
| 2025-10-30 | 2.37 |
| 2025-07-31 | 2.55 |
| 2025-04-23 | 2.37 |
| 2025-01-30 | 2.43 |
| 2024-10-24 | 2.2 |
| 2024-08-01 | 1.98 |
| 2024-04-25 | 2.13 |
| 2024-01-24 | 1.88 |
| 2023-10-26 | 1.64 |
| 2023-08-03 | 1.6 |
| 2023-04-27 | 1.68 |
| 2023-01-26 | 1.66 |
| 2022-10-27 | 1.51 |
| 2022-08-11 | 1.49 |
| 2022-04-28 | 1.32 |
| 2022-01-27 | 1.47 |
| 2021-10-28 | 1.51 |
| 2021-08-05 | 1.35 |
| 2021-04-29 | 1.3 |
| 2021-01-28 | 1.41 |
| 2020-10-29 | 1.27 |
| 2020-08-05 | 1.33 |
| 2020-04-30 | 1.29 |
📰 Related News & Research
No related articles found for "resmed inc".